| Literature DB >> 33857369 |
Nicholas Liu, Elizabeth D Abramyan, Wei Cheng, Bruno Perlatti1, Colin J B Harvey2, Gerald F Bills1, Yi Tang.
Abstract
Lanosterol 14α-demethylase (CYP51) is an important target in the development of antifungal drugs. The fungal-derived restricticin 1 and related molecules are the only examples of natural products that inhibit CYP51. Here, using colocalizations of genes encoding self-resistant CYP51 as the query, we identified and validated the biosynthetic gene cluster (BGC) of 1. Additional genome mining of related BGCs with CYP51 led to production of the related lanomycin 2. The pathways for both 1 and 2 were identified from fungi not known to produce these compounds, highlighting the promise of the self-resistance enzyme (SRE) guided approach to bioactive natural product discovery.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33857369 PMCID: PMC8119659 DOI: 10.1021/jacs.1c01516
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419